Results 201 to 210 of about 195,174 (257)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic review. [PDF]

open access: yesFront Endocrinol (Lausanne)
Wang EM   +8 more
europepmc   +1 more source

The burden of diabetic foot ulcers in a multi‐ethnic Asian cohort

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) are a major source of morbidity among individuals with diabetes mellitus (DM), imposing a substantial burden on healthcare systems. Our institution established a multidisciplinary service aiming to facilitate early specialist intervention for DFU management.
Zongwen Wee   +2 more
wiley   +1 more source

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo   +4 more
wiley   +1 more source

Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2. [PDF]

open access: yesJ Med Chem
Romanyuk Z   +16 more
europepmc   +1 more source

Inhibition of the angiotensin-converting enzyme N-terminal catalytic domain prevents endogenous opioid degradation in brain tissue. [PDF]

open access: yesJCI Insight
Hanak F   +7 more
europepmc   +1 more source

Angiotensin-converting enzyme gene insertion/deletion polymorphism and its impact on response to azithromycin and doxycycline treatment in acne vulgaris patients. [PDF]

open access: yesCaspian J Intern Med
Tavakolizadeh A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy